|
⚲
|
| Proteus Biomedical Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001228295 |
| Sale | 2009-12-17 ($35.0 M Offered, $25.4 M Sold) |
| Fund | |
| Phone | 6506324031 |
| Address | 2600 Bridge Parkway, Suite 101 Redwood City, 94065 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Joy Berberich | |
| Frank Fischer | |
| Immanuel Thangaraj | |
| Ben Pless | |
| Todd Thompson | |
| Terry Gould | |
| George Savage | |
| Mark Zdeblick | |
| David OReilly | |
| Andrew Thompson | |
| Ryan Schwarz | |
| Alan Levy |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
HAAG Robert L
✚
|
0.0 | |
|
Haas Alesia J
✚
|
0.0 | |
|
Haase Bruce N
✚
|
0.0 | |
|
Haben Mary Kay
✚
|
0.0 | |
|
Habib Barry
✚
|
0.0 | |
|
Hackett Group Inc
✚
|
0.0 | |
|
Hackett H Patrick Jr
✚
|
0.0 | |
|
Hadeed Charles P
✚
|
0.0 | |
|
Hadjipateras John C
✚
|
0.0 | |
|
HA-0613 Fund I, a series of Syntax Ventures, LP
✚
|
0.0 |